Images of Patients with ER+/PR+/HER2- Invasive Ductal Carcinoma (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

Images of Patients with ER+/PR+/HER2- Invasive Ductal Carcinoma

Caption

F-18 FES PET images of patients with ER+/PR+/HER2- invasive ductal carcinoma. Left panel: Progressive disease seen at the 8-week time-point in a patient on sequential therapy. Right panel: Stable disease through all 3 time-points, remaining on study therapy for 6.7 months until disease progression on combined vorinostat aromatase inhibitor therapy.

Credit

Image created by Lanell M Peterson, Research Scientist, University of Washington Medical Oncology, Seattle WA.

Usage Restrictions

Please give appropriate credit.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.